Protalix Biotherapeutics Inc. logo

Protalix Biotherapeutics Inc. (PLX)

Market Closed
15 Jun, 20:00
AMEX AMEX
$
2. 06
-0.03
-1.4354%
$
165.17M Market Cap
12.78 P/E Ratio
- Div Yield
561,635 Volume
0.21 Eps
$ 2.09
Previous Close
Add Transaction
Day Range
2.04 2.13
Year Range
1.32 3.19
Want to track PLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Protalix Biotherapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
YL
Yosef Levy Y.D. More Investments Ltd.
220 $257 $453.2 $196.2 76.34%
JC
Joseph Castro Nuveen LLC
90,188 $133,478 $184,885.4 $51,407.4 38.51%
SE
Sima Elimelech Activest Wealth Management
300 $351 $615 $264 75.21%
BO
Barry Oliver Capital Performance Advisors LLP
25,975 $28,404.35 $53,508.5 $25,104.15 88.38%
KK
Kevin Kroskey True Wealth Design LLC
11 $24 $22.88 -$1.12 -4.67%
Alexandra Stickelman
Alexandra Stickelman Root Financial Partners, LLC
128 $278 $263.68 -$14.32 -5.15%
Kevin Bresler
Kevin Bresler TD Waterhouse Canada Inc.
6,000 $4,990.2 $12,420 $7,429.8 148.89%
SAM
Smartleaf Asset Management LLC Smartleaf Asset Management LLC
25,975 $45,196 $53,508.5 $8,312.5 18.39%
Brian Krause
Brian Krause Cascade Financial Partners, LLC
12,000 $17,760 $24,720 $6,960 39.19%
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
250 $536.71 $517.5 -$19.21 -3.58%
MS
Mark Schafer Police & Firemen's Retirement System of New Jersey
18,554 $27,460 $38,221.24 $10,761.24 39.19%